These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8059714)

  • 1. Nitric oxide and prostacyclin treatment of an infant with primary pulmonary hypertension.
    Ivy DD; Wiggins JW; Badesch DB; Kinsella JP; Kelminson LL; Abman SH
    Am J Cardiol; 1994 Aug; 74(4):414-6. PubMed ID: 8059714
    [No Abstract]   [Full Text] [Related]  

  • 2. Is it time to consider domiciliary nitric oxide?
    Goldman AP; Rees PG; Macrae DJ
    Lancet; 1995 Jan; 345(8943):199-200. PubMed ID: 7823701
    [No Abstract]   [Full Text] [Related]  

  • 3. Unsuccessful treatment of pulmonary hypertension by inhaled nitric oxide and aerosolized prostacyclin.
    Tibballs J; Goh TH; McKenzie I; Hochmann M
    Anaesth Intensive Care; 1999 Jun; 27(3):316-7. PubMed ID: 10389572
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.
    Fattouch K; Sbraga F; Bianco G; Speziale G; Gucciardo M; Sampognaro R; Ruvolo G
    J Card Surg; 2005; 20(2):171-6. PubMed ID: 15725144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostacyclin aerosol in an infant with pulmonary hypertension.
    Santak B; Schreiber M; Kuen P; Lang D; Radermacher P
    Eur J Pediatr; 1995 Mar; 154(3):233-5. PubMed ID: 7758525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The perioperative management of portopulmonary hypertension with nitric oxide and epoprostenol.
    Ramsay MA; Spikes C; East CA; Lynch K; Hein HA; Ramsay KJ; Klintmalm GB
    Anesthesiology; 1999 Jan; 90(1):299-301. PubMed ID: 9915339
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide.
    Kelly LK; Porta NF; Goodman DM; Carroll CL; Steinhorn RH
    J Pediatr; 2002 Dec; 141(6):830-2. PubMed ID: 12461501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient effect of epoprostenol and sildenafil combined with iNO for pulmonary hypertension in congenital diaphragmatic hernia.
    De Luca D; Zecca E; Vento G; De Carolis MP; Romagnoli C
    Paediatr Anaesth; 2006 May; 16(5):597-8. PubMed ID: 16677275
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery.
    De Wet CJ; Affleck DG; Jacobsohn E; Avidan MS; Tymkew H; Hill LL; Zanaboni PB; Moazami N; Smith JR
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1058-67. PubMed ID: 15052203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasodilators in the treatment of primary pulmonary hypertension.
    Weir EK; Schremmer B
    Eur Respir J; 1998 Aug; 12(2):263-4. PubMed ID: 9727771
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravenous prostacyclin combined with inhaled nitric oxide therapy for an infant with alveolar capillary dysplasia.
    Kinugasa H; Horigome H; Sugiura M; Saito T; Iijima T; Matsui A
    Pediatr Int; 2002 Oct; 44(5):525-7. PubMed ID: 12225554
    [No Abstract]   [Full Text] [Related]  

  • 12. Nitric oxide for the evaluation and treatment of pulmonary hypertension in congenital heart disease.
    Kovalchin JP; Mott AR; Rosen KL; Feltes TF
    Tex Heart Inst J; 1997; 24(4):308-16. PubMed ID: 9456484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.
    Haraldsson A; Kieler-Jensen N; Nathorst-Westfelt U; Bergh CH; Ricksten SE
    Chest; 1998 Sep; 114(3):780-6. PubMed ID: 9743166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition and management of pulmonary hypertension.
    Wanstall JC; Jeffery TK
    Drugs; 1998 Dec; 56(6):989-1007. PubMed ID: 9878988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous prostacyclin in the treatment of persistent pulmonary hypertension of the newborn refractory to inhaled nitric oxide.
    Golzand E; Bar-Oz B; Arad I
    Isr Med Assoc J; 2005 Jun; 7(6):408-9. PubMed ID: 15984391
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined therapy with inhaled nitric oxide and intravenous epoprostenol (prostacyclin) for critical pulmonary perfusion after the Fontan procedure.
    Miyaji K; Nagata N; Miyamoto T; Kitahori K
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):437-9. PubMed ID: 12579126
    [No Abstract]   [Full Text] [Related]  

  • 17. An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension.
    Mikhail G; Gibbs J; Richardson M; Wright G; Khaghani A; Banner N; Yacoub M
    Eur Heart J; 1997 Sep; 18(9):1499-504. PubMed ID: 9458458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerosolized prostacyclin versus inhaled nitric oxide in children with severe acute respiratory distress syndrome.
    Pappert D; Busch T; Gerlach H; Lewandowski K; Radermacher P; Rossaint R
    Anesthesiology; 1995 Jun; 82(6):1507-11. PubMed ID: 7793662
    [No Abstract]   [Full Text] [Related]  

  • 19. Nitric oxide, oxygen, and prostacyclin in children with pulmonary hypertension.
    Turanlahti MI; Laitinen PO; Sarna SJ; Pesonen E
    Heart; 1998 Feb; 79(2):169-74. PubMed ID: 9538311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxygenation response to NO in newborns with severe pulmonary hypertension.
    Trevisanuto D; Ferrarese P; Biban P; Cantarutti F; Zanardo V
    Acta Paediatr; 1996 Nov; 85(11):1387. PubMed ID: 8955477
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.